Personal CFO Solutions LLC Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

Personal CFO Solutions LLC lowered its holdings in shares of CVS Health Co. (NYSE:CVS) by 62.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 10,020 shares of the pharmacy operator’s stock after selling 16,691 shares during the quarter. Personal CFO Solutions LLC’s holdings in CVS Health were worth $450,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CWA Asset Management Group LLC acquired a new position in shares of CVS Health in the third quarter valued at approximately $777,000. SpiderRock Advisors LLC raised its position in shares of CVS Health by 3.2% in the third quarter. SpiderRock Advisors LLC now owns 10,807 shares of the pharmacy operator’s stock valued at $680,000 after buying an additional 332 shares during the last quarter. Assetmark Inc. raised its position in shares of CVS Health by 9.7% in the third quarter. Assetmark Inc. now owns 410,001 shares of the pharmacy operator’s stock valued at $25,781,000 after buying an additional 36,132 shares during the last quarter. Lindbrook Capital LLC raised its position in shares of CVS Health by 8.8% in the third quarter. Lindbrook Capital LLC now owns 6,524 shares of the pharmacy operator’s stock valued at $410,000 after buying an additional 527 shares during the last quarter. Finally, Tyler Stone Wealth Management raised its position in shares of CVS Health by 83.7% in the third quarter. Tyler Stone Wealth Management now owns 10,169 shares of the pharmacy operator’s stock valued at $639,000 after buying an additional 4,632 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CVS shares. Argus set a $77.00 price objective on shares of CVS Health in a research report on Tuesday, February 18th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. Finally, Piper Sandler dropped their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $69.83.

CVS Health Stock Up 1.7 %

Shares of NYSE:CVS opened at $66.34 on Monday. The stock has a market capitalization of $83.64 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company’s fifty day moving average is $56.42 and its two-hundred day moving average is $56.73. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. CVS Health’s dividend payout ratio (DPR) is presently 72.68%.

Insider Buying and Selling

In other news, Director Michael F. Mahoney acquired 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.